Global Human Parenteral Nutrition Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Human Parenteral Nutrition Market Research Report 2024
Parenteral nutrition is the medical term for infusing a specialized form of food through a vein (intravenously). The goal of the treatment is to cure or prevent malnutrition. Human Parenteral nutrition provides liquid nutrients, including carbohydrates, proteins, fats, vitamins, minerals, and electrolytes. Some people use parenteral nutrition to feed various vitamin or protein supplements through a tube placed into the stomach or small bowel.
According to Mr Accuracy reports new survey, global Human Parenteral Nutrition market is projected to reach US$ 11610 million in 2029, increasing from US$ 6700 million in 2022, with the CAGR of 7.4% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Human Parenteral Nutrition market research.
The market for human parenteral nutrition has witnessed significant growth in recent years, driven by several factors. One of the primary drivers is the increasing prevalence of chronic diseases and medical conditions that require specialized nutrition support. Patients with conditions such as cancer, gastrointestinal disorders, malabsorption syndromes, or those undergoing major surgeries often require HPN to meet their nutritional needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Human Parenteral Nutrition market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Baxter
Allergan
Actavis Inc.
Otsuka Pharmaceutical Factory, Inc.
Grifols, S.A.
B. Braun Melsungen AG
Vifor Pharma
Fresenius Kabi AG
Sichuan Kelun Pharmaceutical Co., Ltd.
Pfizer Inc. (Hospira Inc.)
Amanta Healthcare
Aculife Healthcare
Medipharm
Segment by Type
Carbohydrate Nutrition
Parenteral Lipid Emulsion Nutrition
Single Dose Amino Acid Solution Nutrition
Trace Element Nutrition
Vitamins & Mineral Nutrition
Hospital
Clinic
Nursing Home
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Human Parenteral Nutrition report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to Mr Accuracy reports new survey, global Human Parenteral Nutrition market is projected to reach US$ 11610 million in 2029, increasing from US$ 6700 million in 2022, with the CAGR of 7.4% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Human Parenteral Nutrition market research.
The market for human parenteral nutrition has witnessed significant growth in recent years, driven by several factors. One of the primary drivers is the increasing prevalence of chronic diseases and medical conditions that require specialized nutrition support. Patients with conditions such as cancer, gastrointestinal disorders, malabsorption syndromes, or those undergoing major surgeries often require HPN to meet their nutritional needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Human Parenteral Nutrition market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Baxter
Allergan
Actavis Inc.
Otsuka Pharmaceutical Factory, Inc.
Grifols, S.A.
B. Braun Melsungen AG
Vifor Pharma
Fresenius Kabi AG
Sichuan Kelun Pharmaceutical Co., Ltd.
Pfizer Inc. (Hospira Inc.)
Amanta Healthcare
Aculife Healthcare
Medipharm
Segment by Type
Carbohydrate Nutrition
Parenteral Lipid Emulsion Nutrition
Single Dose Amino Acid Solution Nutrition
Trace Element Nutrition
Vitamins & Mineral Nutrition
Segment by Application
Hospital
Clinic
Nursing Home
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Human Parenteral Nutrition report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source